Dr. David C. Liu

Palliative Medicine
Kaiser Permanente
Kaiser Permanente Ontario Medical Center - Acute Care-Med/Surg Department
2295 S Vineyard Ave, 
Ontario, CA 
Accepting New Patients
Kaiser Permanente
Kaiser Permanente Ontario Medical Center - Acute Care-Med/Surg Department
2295 S Vineyard Ave, 
Ontario, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Liu is a Palliative Medicine provider in Ontario, California. His top areas of expertise are Transcatheter Aortic Valve Replacement (TAVR) and Aortic Valve Replacement. Dr. Liu is currently accepting new patients.

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Palliative Medicine
Licenses
Internal Medicine in CA
Hospital Affiliations
Kaiser Foundation Hospital Fontana/ontario
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

Kaiser Permanente Ontario Medical Center - Acute Care-med/Surg Department
2295 S Vineyard Ave, Ontario, CA 91761

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Enrollment Status: Terminated
Publish Date: May 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Device
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
Enrollment Status: Terminated
Publish Date: March 20, 2024
Intervention Type: Drug, Device
Study Drugs: Apixaban, Warfarin
Study Phase: Phase 3
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

16 Total Publications

Spontaneous Partial Dehiscence of Trifecta Bioprosthetic Valve Leaflet.
Spontaneous Partial Dehiscence of Trifecta Bioprosthetic Valve Leaflet.
Journal: JACC. Case reports
Published: September 16, 2024
Similar Doctors
Expertise in
13
conditions
Dr. Sharon J. Yee
Palliative Medicine | Hematology Oncology | Oncology
Expertise in
13
conditions
Dr. Sharon J. Yee
Palliative Medicine | Hematology Oncology | Oncology

Baldwin Park Medical Center

1011 Baldwin Park Boulevard, 
Baldwin Park, CA 
 (21.7 miles away)
833-574-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sharon Yee is a Palliative Medicine specialist and a Hematologist Oncology provider in Baldwin Park, California. Dr. Yee is highly rated in 13 conditions, according to our data. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Anemia. Dr. Yee is currently accepting new patients.

Expertise in
1
conditions
Dr. Sung W. Park
Palliative Medicine
Expertise in
1
conditions
Dr. Sung W. Park
Palliative Medicine
10999 Riverside Dr Ste 306, 
North Hollywood, CA 
 (44.2 miles away)
818-824-3702
Languages Spoken:
English

Sung Park is a Palliative Medicine provider in North Hollywood, California. Dr. Park is highly rated in 1 condition, according to our data. His top areas of expertise are Diabetic Macular Edema (DME), Visceral Larva Migrans, Toxocariasis, Vitrectomy, and Cataract Removal.

Expertise in
1
conditions
Dr. Samina Qamar
Palliative Medicine
Expertise in
1
conditions
Dr. Samina Qamar
Palliative Medicine

City Of Hope Medical Foundation

1500 E Duarte Rd, 
Duarte, CA 
 (21.9 miles away)
Languages Spoken:
English
See accepted insurances

Samina Qamar is a Palliative Medicine provider in Duarte, California. Dr. Qamar is highly rated in 1 condition, according to our data. Her top area of expertise is Opioid Induced Constipation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liu's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile